Group One Trading’s Agile Therapeutics AGRX Stock Holding History

Group One Trading’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7	Closed	-$14K	–	9062
2021 Q3	$14K	Hold	7	–	–	﹤0.01%	7367
2021 Q2	$19K	Buy	7 +2	+40%	+$6.59K	﹤0.01%	7238
2021 Q1	$20K	Buy	5 +1	+25%	+$5.41K	﹤0.01%	6768
2020 Q4	$25K	Sell	4 -5	-56%	-$29.4K	﹤0.01%	5405
2020 Q3	$54K	Buy	9 +4	+80%	+$22.9K	﹤0.01%	4601
2020 Q2	$30K	Sell	5 -19	-79%	-$98.7K	﹤0.01%	4644
2020 Q1	$88K	Buy	24 +20	+500%	+$115K	﹤0.01%	3390
2019 Q4	$18K	Buy	+4	New	+$14K	﹤0.01%	4401
2018 Q1	–	Sell	-1	Closed	-$7K	–	5448
2017 Q4	$7K	Buy	+1	New	+$9.31K	﹤0.01%	4492

Other funds holding AGRX

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Group One Trading's AGRX Position: Q1 2024 in Review

Group One Trading sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 10 shares — an estimated $20 sold.

Group One Trading first reported a position in AGRX in Q4 2017 and held it in 25 quarters. The position peaked at $260K in Q3 2020. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.

Group One Trading reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 10 Agile Therapeutics shares in Q1 2024, an estimated $20.
Group One Trading first reported a position in Agile Therapeutics in Q4 2017 and held it in 25 quarters.
Group One Trading's Agile Therapeutics position peaked at $260K in Q3 2020.
1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.